GGenetics Read More From Genetic Risk to Preventive SolutionsSeptember 29, 2025 Cardiovascular diseases (CVDs) continue to be the leading cause of mortality globally and in Mexico. Heart attacks, strokes,…
MMedication Read More Rivaroxaban or Combo Therapy: A Winner for All Ages? – MedscapeAugust 21, 2025 Rivaroxaban or Combo Therapy: A Winner for All Ages? MedscapeRivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary Artery…